CTLA4 and systemic lupus erythematosus: Furthermore, a soluble form of CTLA-4 is present in patients with various autoimmune diseases, such as autoimmune thyroid diseases (37, 38), myasthenia gravis (39), and systemic lupus erythematosus (SLE) (40).